Champions Oncology, Inc. (CSBR) earnings
CSBR earnings moved a median of -0.21% by the close. Quarterly and annual CSBR reports and results, each read against the price at its own news timestamp. Back to the CSBR overview →
12 measured CSBR earnings events.
Where these CSBR earnings landedvs 12 measured CSBR earnings reactions
| Middle 50% of CSBR earnings reactions | -3.99% to +2.86% |
|---|---|
| Median reaction (to close) | -0.21% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 CSBR earnings events with a measured close landed between -3.99% and +2.86%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-K CHAMPIONS ONCOLOGY, INC. For: Apr 30 | SEC filing · Form 10-K | -11.27% | -14.66% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 | SEC filing · Form 10-Q | -0.18% | +10.71% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Oct 31 | SEC filing · Form 10-Q | -6.17% | -13.50% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 | SEC filing · Form 10-Q | +0.84% | +0.72% | |
| Form 10-K CHAMPIONS ONCOLOGY, INC. For: Apr 30 | SEC filing · Form 10-K | +0.16% | -1.48% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 | SEC filing · Form 10-Q | +0.11% | +9.26% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Oct 31 | SEC filing · Form 10-Q | -1.97% | -8.44% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jul 31 | SEC filing · Form 10-Q | +1.52% | +9.78% | |
| Form 10-K CHAMPIONS ONCOLOGY, INC. For: Apr 30 | SEC filing · Form 10-K | — | -2.51% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Jan 31 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q CHAMPIONS ONCOLOGY, INC. For: Oct 31 | SEC filing · Form 10-Q | — | -0.42% |
Keep exploring
More CSBR: analyst actions → · SEC filings → · CSBR overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ISODIOL INTERNATIONAL INC (ISOLF) | 134 | +0.20% | 52% |
| ContextLogic Inc. (LOGC) | 132 | 0.00% | 40% |
| INNATE PHARMA (IPHYF) | 130 | 0.00% | 0% |
| Deciphera Pharmaceuticals, Inc. (DCPH) | 129 | +0.04% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.